Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Pediatrics/Neonatology | Genetic Disease | Neurology

Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 3 Last 

California

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Sacramento California 95817

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Georgia

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Kansas

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Maryland

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Massachusetts

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Cambridge Massachusetts

Patients are needed to participate in a clinical research study evaluating agalsidase beta for the treatment of Fabry Disease

Cambridge Massachusetts 02142

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Michigan

Grand Rapids Michigan 49525

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Minnesota

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study of Gabapentin and placebo to evaluate Fabry Disease or Neuropathic Pain

New York

New York New York 10016

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

North Carolina

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Ohio

Cincinnati Ohio 45229-3039

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Columbus Ohio 43212

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Pennsylvania

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Texas

Baylor Research Institute
Dallas Texas 75204

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

View More ▼

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Virginia

Fairfax Virginia 22030

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Washington

Seattle Washington 98195-6320

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Wisconsin

Milwaukee Wisconsin 532261

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Argentina

Pilar B1629ODT

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Australia

North Adelaide 5006

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

UPDATED

Parkville Victoria 3050

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Parkville Victoria 3050

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Victoria 3050

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Austria

Graz A-8036

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Salzburg A-5020

A clinical research study for the treatment of Fabry's Disease

Wien A-1090

A clinical research study for the treatment of Fabry's Disease

Belgium

Liège

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Brazil

Porto Alegre 90035-001

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Ribeirao Preto São Paulo 14048-900

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Canada

Calgary Alberta T3B 6A8

A Phase 3 clinical study for patients with Fabry Disease

Edmonton Alberta T6G 2H7

A Phase 3 clinical study for patients with Fabry Disease

Halifax Nova Scotia B3H 1V8

A Phase 3 clinical study for patients with Fabry Disease

Halifax Nova Scotia B3K 6R8

A Phase 3 clinical study for patients with Fabry Disease

Kingston Ontario K7L 3J6

A Phase 3 clinical study for patients with Fabry Disease

View More ▼

London Ontario N6C 2V5

A Phase 3 clinical study for patients with Fabry Disease

Montreal Quebec H3T1P1

A clinical research study for the treatment of Fabry Disease

Montreal Quebec H4J 1C5

A Phase 3 clinical study for patients with Fabry Disease

Montreal Quebec H4J 1C5

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

First 1 2 3 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.